Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 9—September 2015
Emerging Infections Program

Emerging Infections Program Efforts to Address Health Equity

James L. HadlerComments to Author , Duc Vugia, Nancy M. Bennett, and Matthew R. Moore
Author affiliations: Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA (J.L. Hadler); California Emerging Infections Program, California Department of Public Health, Richmond, California, USA (D.J. Vugia); New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, USA (N.M. Bennett); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.R. Moore)

Main Article

Figure 2

Framework for considering social disparities of health determined by the Commission on Social Determinants of Health, World Health Organization (3).

Figure 2. Framework for considering social disparities of health determined by the Commission on Social Determinants of Health, World Health Organization (3).

Main Article

  1. US Department of Health and Human Services. Healthy People 2010: understanding and improving health. 2nd ed. Washington (DC): US Government Printing Office; 2000. p. 11 [cited 2015 Apr 11].
  2. US Department of Health and Human Services. Healthy People 2020 topics and objectives: public health infrastructure [cited 2015 Apr 11].
  3. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the Commission on Social Determinants of Health. Geneva: the Commission; 2008 [cited 2015 Apr 11].
  4. Centers for Disease Control and Prevention. Emerging Infections Programs [cited 2015 Apr 11].
  5. Pinner  RW. Addressing the challenges of emerging infectious disease. Am J Med Sci. 1996;311:38. DOIPubMed
  6. Pinner  RW, Rebmann  CA, Schuchat  A, Hughes  JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9:7817.PubMed
  7. Pinner  RW, Lynfield  R, Hadler  JL, Schaffner  W, Farley  MM, Frank  ME, Cultivation of an adaptive domestic network for surveillance and evaluation of emerging infections. [zzz–zzz.]. Emerg Infect Dis. 2015;21:14991509.
  8. Krieger  N, Chen  JT, Waterman  PD, Rehkopf  DH, Subramanian  SV. Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: The Public Health Disparities Geocoding Project. Am J Public Health. 2005;95:31223. DOIPubMed
  9. Public Health Disparities Geocoding Project Monograph [cited 2015 Feb 15].
  10. Bennett  NM, Buffington  J, LaForce  FM. Pneumococcal bacteremia in Monroe County, New York: incidence, case fatality, and comorbid conditions. Am J Public Health. 1992;82:15136. DOIPubMed
  11. Robinson  KA, Baughman  W, Rothrock  G, Barrett  NL, Pass  M, Lexau  C, Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998. Opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:172935. DOIPubMed
  12. Flannery  B, Schrag  S, Bennett  NM, Lynfield  R, Harrison  LH, Reingold  A, Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291:2197203. DOIPubMed
  13. Talbot  TR, Poehling  KA, Hartert  TV, Arbogast  PG, Halasa  NB, Mitchel  E, Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004;23:72631. DOIPubMed
  14. Poehling  KA, Talbot  TR, Griffin  MR, Craig  AS, Whitney  CG, Zell  E, Decline in invasive pneumococcal disease among young infants and elimination of racial differences in disease rates following introduction of the pneumococcal conjugate vaccine. JAMA. 2006;295:166874. DOIPubMed
  15. Wortham  JM, Zell  ER, Pondo  T, Harrison  LH, Schaffner  W, Lynfield  R, Racial disparities in invasive Streptococcus pneumoniae infections, 1998–2009. Clin Infect Dis. 2014;58:12507. DOIPubMed
  16. US Department of Health and Human Services (DHHS). HHS action plan to reduce health disparities: a nation free of disparities in health and health care. Washington (DC): The Department; 2011 [cited 2015 Apr 12].
  17. Ramakrishnan  M, Moisi  JC, Klugman  KP, Iglesias  JM, Grant  LR, Mpoudi-Etame  M, Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:32937. DOIPubMed
  18. Muhammad  RD, Oza-Frank  R, Zell  E, Link-Gelles  R, Narayan  KM, Schaffner  W, Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis. 2013;56:e5967. DOIPubMed
  19. Nuorti  JP, Butler  JC, Gelling  L, Kool  JL, Reingold  AL, Vugia  DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:18290. DOIPubMed
  20. Burton  DC, Flannery  B, Bennett  NM, Farley  MM, Gershman  K, Harrison  LH, Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health. 2010;100:190411. DOIPubMed
  21. Soto  K, Petit  S, Hadler  JL. Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ethnicity in Connecticut, 1998–2008. Public Health Rep. 2011;126(Suppl 3):818 .PubMed
  22. Schuchat  A, Oxtoby  M, Cochi  S, Sikes  RK, Hightower  A, Plikaytis  B, Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis. 1990;162:6727. DOIPubMed
  23. Schwartz  B, Schuchat  A, Oxtoby  MJ, Cochi  SL, Hightower  A, Broome  CV. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA. 1991;266:11124. DOIPubMed
  24. Schrag  SJ, Zywicki  S, Farley  MM, Reingold  AL, Harrison  LH, Lefkowitz  LB, Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:1520. DOIPubMed
  25. Centers for Disease Control and Prevention. Diminishing racial disparities in early-onset neonatal group B streptococcal disease—United States, 2000–2003. MMWR Morb Mortal Wkly Rep. 2004;53:5025 .PubMed
  26. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003–2005. MMWR Morb Mortal Wkly Rep. 2007;56:7015 .PubMed
  27. Centers for Disease Control and Prevention. Trends in perinatal group B streptococcal disease–United States, 2000–2006. MMWR Morb Mortal Wkly Rep. 2009;58:10912 .PubMed
  28. Jordan  HT, Farley  MM, Craig  A, Mohle-Boetani  J, Harrison  LH, Petit  S, Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, populations-based analysis. Pediatr Infect Dis J. 2008;27:105764. DOIPubMed
  29. Weston  EJ, Pondo  T, Lewis  MM, Martell-Cleary  P, Morin  C, Jewell  B, The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J. 2011;30:93741. DOIPubMed
  30. O’Brien  KL, Beall  B, Barrett  NL, Cieslak  PR, Reingold  A, Farley  MM, Epidemiology of invasive group A Streptococcus disease in the United States, 1995–1999. Clin Infect Dis. 2002;35:26876 . DOIPubMed
  31. Passaro  DJ, Smith  DS, Hett  EC, Reingold  AL, Daily  P, Van Beneden  CA, Invasive group A streptococcal infections in the San Francisco Bay area, 1989–1999. Epidemiol Infect. 2002;129:4718. DOIPubMed
  32. Yousey-Hindes  KM, Hadler  JL. Neighborhood socioeconomic status and influenza hospitalizations among children: New Haven County, Connecticut, 2003–2010. Am J Public Health. 2011;101:17859. DOIPubMed
  33. Tam  K, Yousey-Hindes  K, Hadler  JL. Influenza-related hospitalization of adults associated with low census tract socioeconomic status and female sex in New Haven County, Connecticut, 2007–2011. Influenza Other Respir Viruses. 2014;8:274–81.
  34. Bemis  K, Marcus  R, Hadler  JL. Socioeconomic status and campylobacteriosis, Connecticut, USA, 1999–2009 [Letter]. Emerg Infect Dis. 2014;20:12402 .PubMed
  35. Niccolai  LM, Julian  PJ, Bilinski  A, Mehta  NR, Meek  JI, Zelterman  D, Geographic povery and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008–2009. Am J Public Health. 2013;103:15663. DOIPubMed
  36. Lembo  NJ. Pneumococcal infections in children with sickle cell disease: increased incidence, immunological defects, vaccine failure, and prospects for the future. J Natl Med Assoc. 1981;73:435 .PubMed
  37. Roongpiboonsopit  D, Harimi  HA. Quality assessment of online street and rooftop geocoding services. Cartogr Geogr Inf Sci. 2010;37:301–18.
  38. Hampton  KH, Fitch  MK, Allshouse  WB, Doherty  IA, Gesink  DC, Leone  PA, Mapping health data: improved privacy protection with donut method geomasking. Am J Epidemiol. 2010;172:10629. DOIPubMed
  39. McEwen  BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:1719. DOIPubMed
  40. Shonkoff  JP, Garner  AS; Committee on Psychosocial Aspects of Child and Family Health. Committee on Early Childhood, Adoption, and Dependent Care; Section on Developmental and Behavioral Pediatrics. The lifelong effects of early childhood adversity and toxic stress. Pediatrics. 2012;129:e23246. DOIPubMed

Main Article

Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.